3 completed, 2 terminated, 1 recruiting, 1 unknown. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Terminated 2, Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Ice: new trials by email Literature Review of Ice trials Research Report on Ice
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma Pembrolizumab plus Chemotherapy (ICE or DHAP) - Classical Hodgkin Lymphoma | Phase 2 | Recruiting | University of Cologne | 29 | 2024-03-05 | 2024-08-23 |
| A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma ICE [ifosfamide+carboplatin+etoposide], GEMOX [gemcitabine+oxaliplatin], Tislelizumab - Peripheral T-cell Lymphoma, NK/T-cell Lymphoma | Phase 1 / Phase 2 | Terminated | Antengene Corporation | 56 | 2020-08-18 | 2026-01-05 |
| Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma Chidamide with ICE regimen - Peripheral T Cell Lymphoma | Phase 2 | Unknown | Yuankai Shi | 35 | 2016-09-01 | 2016-08-05 |
| A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) MEDI-551 2 mg/kg, Rituximab, ICE - Diffuse Large B-Cell Lymphoma | Phase 2 | Completed | MedImmune LLC | 187 | 2012-02-27 | 2018-03-12 |
| Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) ofatumumab + ICE, ofatumumab + DHAP - Lymphoma, Large-Cell, Diffuse | Phase 2 | Completed | GlaxoSmithKline | 61 | 2009-05-01 | 2013-03-12 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer therapeutic autologous lymphocytes, Ifosfamide, carboplatin, and etoposide (ICE) regimen, Cyclophosphamide, Thiotepa, Carboplatin (CTC) or STAMP V (CTC) - Breast Cancer | Phase 2 | Terminated | Barbara Ann Karmanos Cancer Institute | 7 | 2007-08-01 | 2016-02-17 |
| Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study Intra-Cardiac Echocardiography guided Cardioversion, Intracardiac Echo, ICE - Atrial Fibrillation | Phase 1 / Phase 2 | Completed | EP MedSystems | 95 | 2005-03-01 | 2011-05-11 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma, Non-Hodgkin (2) · Lymphoma, T-Cell, Peripheral (2) · Atrial Fibrillation (1) · Breast Neoplasms (1) · Lymphoma (1) · Lymphoma, Extranodal NK-T-Cell (1) · Neoplasms (1) · Recurrence (1)
Antengene Corporation (1) · Barbara Ann Karmanos Cancer Institute (1) · EP MedSystems (1) · GlaxoSmithKline (1) · MedImmune LLC (1) · University of Cologne (1) · Yuankai Shi (1)
United States (3) · Germany (2) · Canada (1) · China (1) · Czechia (1) · France (1) · Hungary (1) · Israel (1) · Netherlands (1) · Poland (1) · Russia (1) · Spain (1) · Turkey (Türkiye) (1)
Andreas Engert, Prof. (1) · Lawrence G. Lum, MD, DSc (1) · Sanjeev Saksena, MD, FACC (1) · Yang Yu, MD (1)
PMID 20852299, PMID 23692856, PMID 42438166
P30CA022453 (1)